India receives Sputnik V vaccine consignment

After Covishield and Covaxin, Sputnik V, developed by Gamaleya National Research Institute of Epidemiology and Microbiology in Moscow, is the third Covid-19 vaccine to get emergency use approval in India.

According to the guidelines, the vaccine is indicated for active immunisation to prevent Covid-19 in individuals over 18 years of age and it needs to be stored at a temperature of minus 18-degree Celsius in liquid form.